Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Vistide approved in U.S.

July 5, 1996

Various research groups announce independent discovery of receptor for HIV infection

July 5, 1996

CryptoGam demonstrates clear antimicrobial effect in clinical trial

July 5, 1996

Synovir clinical program expanded

July 5, 1996

Phase III trials of Alferon N Injection initiated in HIV-positive patients

July 5, 1996

CPMP approves saquinavir for marketing

July 5, 1996

HIV protease inhibitors reported by Pharmacia & Upjohn

July 5, 1996

Glaxo Wellcome, Vertex license anti-HIV patents from Searle

July 5, 1996

Second receptor for HIV infection reported

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...